You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PTK7-Expressing Tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, NSCLC (NSCLC) Trial in Worldwide (Cofetuzumab Pelidotin)

Recruiting
  • Cancer
  • Non-small Cell Lung Cancer (NSCLC)
  • Cofetuzumab Pelidotin
  • Birmingham, Alabama
  • +25 more
Jan 31, 2023

Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Embryonal Tumor Trial in Houston ((C7R)-GD2.CART cells, Cyclophosphamide,

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +3 more
  • (C7R)-GD2.CART cells
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Feb 7, 2022

Solid Tumor Trial in Belgium, Netherlands, United Kingdom (SYD985 + Niraparib)

Active, not recruiting
  • Solid Tumor
  • SYD985 + Niraparib
  • Antwerp, Belgium
  • +5 more
Jan 23, 2023

Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma Trial in United States (Enoblituzumab)

Completed
  • Neuroblastoma
  • +5 more
  • Palo Alto, California
  • +5 more
Feb 4, 2022

Hepatocellular Cancer, AFP Expressing Tumors Trial in Worldwide (Autologous genetically modified AFP?³³²T cells)

Active, not recruiting
  • Hepatocellular Cancer
  • AFP Expressing Tumors
  • Autologous genetically modified AFPᶜ³³²T cells
  • Phoenix, Arizona
  • +20 more
Aug 26, 2022

NSCLC, NSCLC, Non-Small Cell Lung Carcinoma Trial in United States (efineptakin alfa, Atezolizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +4 more
  • Mobile, Alabama
  • +14 more
May 12, 2022

Metastatic Cancer, Epithelial Tumor Trial in Santa Monica, Liverpool, Oxford (NG-641 in combination with Nivolumab)

Recruiting
  • Metastatic Cancer
  • Epithelial Tumor
  • NG-641 in combination with Nivolumab
  • Santa Monica, California
  • +2 more
Mar 16, 2022

Epithelial Tumor, Metastatic Cancer Trial in United Kingdom, United States (NG-350A plus Pembrolizumab)

Recruiting
  • Epithelial Tumor
  • Metastatic Cancer
  • NG-350A plus Pembrolizumab
  • Santa Monica, California
  • +3 more
May 4, 2022

Relapsed Neuroblastoma, Refractory Neuroblastoma, Relapsed Osteosarcoma Trial in Houston (C7R-GD2.CART cells, Cyclophosphamide,

Recruiting
  • Relapsed Neuroblastoma
  • +6 more
  • C7R-GD2.CART cells
  • +2 more
  • Houston, Texas
  • +1 more
Nov 12, 2021

Protein Tyrosine Kinase 7 (PTK7) in Non-small Cell Lung Cancer

Completed
  • Tumor Progression
    • Taipei, Taiwan
      Jin-Yuan Shih
    Mar 24, 2020

    Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

    Terminated
    Has Results
    • Breast Neoplasms
    • Saint Louis, Missouri
      Washington University School of Medicine
    Oct 31, 2022

    Neuroblastoma Trial in Houston (GINAKIT Cells, Cyclophosphamide, Fludarabine)

    Active, not recruiting
    • Neuroblastoma
    • GINAKIT Cells
    • +2 more
    • Houston, Texas
      Texas Children's Hospital
    Jan 18, 2023

    Bladder Cancer Trial in Shanghai ([68Ga]-NOTA-SGC8)

    Recruiting
    • Bladder Cancer
    • [68Ga]-NOTA-SGC8
    • Shanghai, Shanghai, China
      Renji Hospital
    Aug 14, 2023

    Cervical Cancer, Prostate Cancer Metastatic, Breast Cancer Trial (²¹²Pb-DOTAM-GRPR1)

    Recruiting
    • Cervical Cancer
    • +5 more
    • Chicago, Illinois
    • +3 more
    Jan 24, 2023

    Solid Tumor, Adult, Advanced Solid Tumor, Advanced Renal Cell Carcinoma Trial in Australia (89Zr-TLX250, 177Lu-TLX250 and

    Recruiting
    • Solid Tumor, Adult
    • +2 more
    • 89Zr-TLX250
    • 177Lu-TLX250 and Peposertib
    • North Ryde, New South Wales, Australia
    • +4 more
    May 22, 2023

    HER2 Expressing or Mutated Advanced Malignant Solid Tumors Trial in China (GQ1005)

    Recruiting
    • HER2 Expressing or Mutated Advanced Malignant Solid Tumors
    • Beijing, Beijing, China
    • +19 more
    Nov 23, 2023

    Tumor, Solid Trial in Essen (68Ga-FAPI-46 PET Scan)

    Recruiting
    • Tumor, Solid
    • 68Ga-FAPI-46 PET Scan
    • Essen, NRW, Germany
      Department of Nuclear medicine, University hospital Essen
    Dec 15, 2021

    Melanoma, Non Small Cell Lung Cancer Trial in United States (enoblituzumab plus ipilimumab)

    Completed
    • Melanoma
    • Non Small Cell Lung Cancer
    • enoblituzumab plus ipilimumab
    • Los Angeles, California
    • +9 more
    Feb 4, 2022

    Locally Advanced or Metastatic Solid Tumors Trial in Beijing (MSC-IFNa, Nab paclitaxel, Cyclophosphamide)

    Recruiting
    • Locally Advanced or Metastatic Solid Tumors
    • MSC-IFNα
    • +3 more
    • Beijing, China
      Department of Biotherapeutic, Chinese PLA General Hospital
    Jan 29, 2023

    Sarcoma Trial in Houston (Autologous HER2-specific T cells, Fludarabine, Cyclophosphamide)

    Active, not recruiting
    • Sarcoma
    • Autologous HER2-specific T cells
    • +3 more
    • Houston, Texas
    • +1 more
    Nov 21, 2022

    Advanced Solid Tumor Trial (SHR-4602 for injection)

    Not yet recruiting
    • Advanced Solid Tumor
    • SHR-4602 for injection
    • (no location specified)
    Apr 6, 2023

    Advanced Solid Tumor, Urinary Bladder Tumor, Pancreatic Tumors Trial in Worldwide (BT8009, Nivolumab)

    Recruiting
    • Advanced Solid Tumor
    • +4 more
    • Denver, Colorado
    • +20 more
    Nov 22, 2022

    Advanced Solid Tumor Trial in Dallas (TCRT-ESO-A2)

    Withdrawn
    • Advanced Solid Tumor
    • TCRT-ESO-A2
    • (no location specified)
    Aug 31, 2022

    Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

    Terminated
    • Mesothelioma
    • +12 more
    • MGD009
    • Los Angeles, California
    • +19 more
    Feb 4, 2022

    Advanced Solid Tumor, Metastatic Solid Tumor Trial (89Zr?DFO?REGN5054, cemiplimab)

    Not yet recruiting
    • Advanced Solid Tumor
    • Metastatic Solid Tumor
    • (no location specified)
    Aug 5, 2022